Litcius/Paper detail

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies

Makoto Inada, Masahiro Ishikane, Mari Terada, Akihiro Matsunaga, Kenji Maeda, K. Tsuchiya, Kenji Miura, Yu Sairenji, Noriko Kinoshita, Mugen Ujiie, Satoshi Kutsuna, Yukihito Ishizaka, Hiroaki Mitsuya, Norio Ohmagari

2021Journal of Infection and Chemotherapy11 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)VirologyAntibodyAsymptomaticSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neutralizing antibody2019-20 coronavirus outbreakMedicineInhibitory postsynaptic potentialInternal medicineImmunologyVirusInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies | Litcius